Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV
Phase 2
12
about 9 months
18+
1 site in HI
What this study is about
This trial is testing whether tirzepatide helps with weight loss and reduces chronic inflammation in people living with HIV. Participants will receive tirzepatide, a medication, for 261 days. It aims to measure changes in weight, body composition, liver health, inflammatory markers, and other factors.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Tirzepatide
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
tirzepatide
injection (Injection)
Primary: Change in Baseline Body Weight
Secondary: Body composition, Change in Inflammatory Markers: IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, Waist circumference
Immune, Infectious